Intrinsic Value of S&P & Nasdaq Contact Us

BioNTech SE BNTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • DE • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$106.49
+8.2%
Analyst Price Target
$137.38
+39.6%

Stock Statistics — BNTX

BioNTech SE (BNTX) has a market capitalization of $24.73B and trades at $98.41. The 52-week range is 79.52-124.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -21.8, Earnings Per Share (EPS) of $-4.51, annual revenue of $2.76B.

The stock has a beta of 1.59, operates in the Healthcare sector.

Trading Data
Current Price$98.41
52-Week Range79.52-124
Volume1.09M
Avg Volume (30D)1.14M
Market Cap$24.73B
Beta (1Y)1.59
Company
IPO Date2019-10-10
Employees6,772
CEOUgur Sahin
CountryDE
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS09075V1026
CUSIP09075V102
Income (Latest Year)
Revenue$2.76B
Gross Profit$2.14B
EBITDA$-256.17M
Operating Income$-623.87M
Net Income$-1.09B
EPS$-4.51
EPS Diluted$-4.51
Shares Outstanding$241.7M
Balance Sheet (Latest Year)
Total Assets$21.98B
Current Assets$16.14B
Cash & ST Investments$14.83B
Total Liabilities$2.76B
Total Debt$267.29M
Net Debt$-7.4B
Total Equity$19.22B
Debt / Equity0.01
Valuation Ratios
P/E Ratio-21.8
P/S Ratio8.97
P/B Ratio1.29
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message